Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study
Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. The Lancet Haematology 2015, 2: e408-e416. PMID: 26686042, DOI: 10.1016/s2352-3026(15)00151-9.Peer-Reviewed Original ResearchConceptsMultiple myelomaFinancial toxicityElectronic health recordsTertiary academic medical centerCross-sectional pilot studyPatient-reported useTreatment costsFinancial burdenNon-married statusAcademic medical centerExtended treatment durationQuality of lifeCross-sectional surveyLower household incomePatients' electronic health recordsPatient-reported financial toxicityHigh financial burdenEligible patientsRoutine followMultivariable analysisMedication adherenceMyeloma treatmentOngoing treatmentCOST scoreMedical Center